Tetronothiodin, a novel CCKB receptor ligand, antagonizes cholecystokinin-induced Ca2+ mobilization in a pituitary cell line
- 6 October 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 221 (1) , 99-105
- https://doi.org/10.1016/0014-2999(92)90777-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Rationally designed "dipeptoid" analogs of CCK. .alpha.-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic propertiesJournal of Medicinal Chemistry, 1991
- Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260Brain Research, 1990
- Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329Journal of Neuroscience, 1990
- The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the ratEuropean Journal of Pharmacology, 1990
- Postponement of Satiety by Blockade of Brain Cholecystokinin (CCK-B) ReceptorsScience, 1989
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260Journal of Medicinal Chemistry, 1989
- CCK-A receptors in the rat interpeduncular nucleus: evidence for a presynaptic locationBrain Research, 1988
- Classification and function of CCK receptorsTrends in Pharmacological Sciences, 1987
- A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusScience, 1985
- Cholecystokinin Receptors in Mammalian Brain: A Comparative Characterization and VisualizationAnnals of the New York Academy of Sciences, 1985